US SB4333 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 26 2022 - 25% progression, died in committee
Action: 2022-05-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 26 2022 - 25% progression, died in committee
Action: 2022-05-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to deem certain products regulated by the Food and Drug Administration as drugs.
Title
CLEAR Act Consistent Legal Evaluation And Regulation of Medical Products Act
Sponsors
| Sen. Tina Smith [D-MN] | Sen. Roger Marshall [R-KS] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-05-26 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB7667 (Related) 2022-06-09 - Received in the Senate.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/4333/all-info |
| Text | https://www.congress.gov/117/bills/s4333/BILLS-117s4333is.pdf |
